The clinical implications of gemcitabine radiosensitization

Clinical Cancer Research

Volumn 7, Issue 2, 2001, Pages 226-228

  Doyle, Todd H ^a   Mornex, Francoise ^b   Gillies McKenna, W Gillies ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b Nephrology and Renal Transplantation   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GEMCITABINE;

ANTINEOPLASTIC ACTIVITY; CANCER RESEARCH; DNA SYNTHESIS INHIBITION; EDITORIAL; ENZYME PHOSPHORYLATION; PRIORITY JOURNAL; RADIOSENSITIZATION;

APOPTOSIS; CASPASES; CELL SURVIVAL; COBALT RADIOISOTOPES; DEOXYCYTIDINE; HUMANS; NEOPLASMS; RADIATION-SENSITIZING AGENTS;

EID: 0035129810     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (19)

1. Evaluation of the antitumor activity of gemcitabine
2. Activity of gemcitabine in patients with non-small cell lung cancer
3. Phase II study of gemcitabine in previously platinum-treated ovarian cancer patients
4. Efficacy and safety profile of gemcitabine in non-small cell lung cancer
5. Action of 2′2′-difluorodeoxycytidine on DNA synthesis
6. Molecular effects of 2′2′-difluorodeoxycytidine (gemcitabine) on DNA replication in intact HL-60 cells
7. Gemcitabine: A cytidine analog active against solid tumors
8. Metabolism of 2′2′-difluoro-2′-deoxycytidine and radiation sensitization of human colon carcinoma cells
9. Delayed radiosensitization of human colon carcinoma cells after a brief exposure to 2′2′-difluoro-2′-deoxycytidine (gemcitabine)
10. Gemcitabine and radiosensitization in human tumor cells
11. Radiosensitization of pancreatic cancer cells by 2′2′-difluoro-2′-deoxycytidine
12. Kinetics of mouse jejunum radiosensitization by 2′2′-difluoredeoxycytidine (gemcitabine) and its relationship with pharmacodynamics of DNA synthesis inhibition and cell-cycle redistribution in crypt cells
13. Radiosensitizing potential of gemcitabine within the cell cycle in vitro
14. Radiosensitization of mouse sarcoma cells by fludarabine (F-ara-A) or gemcitabine (dFdC), two nucleoside analogues, is not mediated by an increased induction or repair inhibition of DNA double strand breaks as measured by pulsed field gel electrophoresis
15. The role of apoptosis in 2′2′-difluoro-2′-deoxycytidine (gemcitabine)-mediated radiosensitization
16. Apoptosis, p53, and tumor cell sensitivity to anticancer agents
17. Phase I trial of radiation concurrent with low dose gemcitabine for head and neck cancer: High mucosal and pharyngeal toxicity
18. Phase I trial of twice-weekly gemcitabine and concurrent radiation in patients with advanced pancreatic cancer